logo
Select company
Select metric
$ -1.6MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
41
Sector
47
Industry
50
History
60
$ 5.45Close
$ 1.15 - $ 6.67 52-Week Range
Ticker Information

Ticker

PRME

Company Name

PRIME MEDICINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PRIME MEDICINE INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRME - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -1.6M
3/31/2025$ -1.72M
12/31/2024$ 141.47M
9/30/2024$ 74.58M
6/30/2024$ -64.98M
3/31/2024$ -39.3M
12/31/2023$ -146.05M
9/30/2023$ -3.99M
6/30/2023$ 28.34M
12/31/2022$ 2.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PRIME MEDICINE INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -112.17M.
  • Over the past 5 years, PRIME MEDICINE INC's average CF - Chg. Cash has been $ -11.17M.
  • The median CF - Chg. Cash for PRIME MEDICINE INC during this period was $ -1.72M
  • PRIME MEDICINE INC reached its highest CF - Chg. Cash over the past 5 years at $ 141.47M.
  • The lowest CF - Chg. Cash recorded by PRIME MEDICINE INC in the same timeframe $ -146.05M

PRIME MEDICINE INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
PGEN : PRECIGEN INC $ 4.15MDNTH : DIANTHUS THERAPEUTICS INC $ -300.77MABSI : ABSCI CORP $ -5.3MOCGN : OCUGEN INC $ 11.32MQSI : QUANTUM-SI INC $ -37.36MLENZ : LENZ THERAPEUTICS INC $ -46.43MACOG : ALPHA COGNITION INC $ 38.27MCBUS : CIBUS INC $ 6.44MVSTM : VERASTEM INC $ 80.95MTVRD : TVARDI THERAPEUTICS INC $ -23.8M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

PRME - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -146.05M

Minimum

Dec 31, 2023

$ 141.47M

Maximum

Dec 31, 2024

$ -11.17M

Average

$ -1.72M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M